AL HB364

Physicians and nurse practitioners must discuss opioid risks with patients before prescribing an initial prescription and again before a third prescription of Schedule II controlled substances or opioid pain relief drugs for acute or chronic pain

Required discussion topics include: specific reasoning for prescribing, alternative treatments, risks of addiction and overdose even when used as prescribed, dangers of mixing with alcohol or benzodiazepines, risks of physical or psychological dependence, and risks of exceeding prescribed dosage

Prescribers must document the conversation and specific reason for prescribing in the patient's medical records

For patients 18 years of age or younger, the discussion must occur with the parent or legal guardian instead of the patient

Exemptions apply to patients in active cancer treatment, receiving hospice or palliative care, residing in long-term care facilities, or being treated for substance abuse or opioid dependence; effective October 1, 2026